Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Acq. announced Director departure CC transcript Quarterly results
|
Aegerion Pharmaceuticals, Inc. (AEGR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
12/01/2016 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
11/30/2016 |
4
| Plutzky Jorge MD (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
11/30/2016 |
4
| PERRY GREGORY D (See Remarks) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns:
| Disposed/sold 200,000 options to buy
@ $19.58, valued at
$3.9M
Disposed/sold 40,000 options to buy
@ $19.52, valued at
$780.8k
Disposed/sold 200,000 options to buy
@ $5.71, valued at
$1.1M
Disposed/sold 69,000 options to buy
@ $2.46, valued at
$169.7k
Disposed/sold 35,000 restricted stock units
@ $0 |
|
11/30/2016 |
4
| Louis Roger (Chief Compliance Officer) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
11/30/2016 |
4
| Harshbarger Benjamin (General Counsel and Secretary) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
11/30/2016 |
4
| Chan Barbara Y (VP, Chief Accounting Officer) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
11/30/2016 |
4
| Buono Linda (Sr. VP, Human Resources) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
11/30/2016 |
4
| VANLENT ANNE (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns:
| Disposed/sold 4,000 shares
@ $0 Disposed/sold 14,700 options to buy
@ $37.66, valued at
$553.6k
Disposed/sold 5,012 options to buy
@ $32.55, valued at
$163.1k
Disposed/sold 18,000 options to buy
@ $17.98, valued at
$323.6k
|
|
11/30/2016 |
4
| THOMAS PAUL (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns:
| Disposed/sold 36,978 shares
@ $0 Disposed/sold 23,521 options to buy
@ $15.26, valued at
$358.9k
Disposed/sold 12,854 options to buy
@ $15, valued at
$192.8k
Disposed/sold 14,700 options to buy
@ $64.73, valued at
$951.5k
Disposed/sold 5,012 options to buy
@ $32.55, valued at
$163.1k
Disposed/sold 18,000 options to buy
@ $17.98, valued at
$323.6k
|
|
11/30/2016 |
4
| Szela Mary T (CEO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
11/30/2016 |
4
| Stern Donald K (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
11/30/2016 |
4
| SMITH SANDFORD D (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns:
| Disposed/sold 2,890 shares
@ $0 Disposed/sold 16,435 options to buy
@ $16.28, valued at
$267.6k
Disposed/sold 8,569 options to buy
@ $15, valued at
$128.5k
Disposed/sold 14,700 options to buy
@ $64.73, valued at
$951.5k
Disposed/sold 5,012 options to buy
@ $32.55, valued at
$163.1k
Disposed/sold 18,000 options to buy
@ $17.98, valued at
$323.6k
Disposed/sold 40,000 options to buy
@ $18.26, valued at
$730.4k
Disposed/sold 8,888 restricted stock units
@ $0 |
|
11/30/2016 |
4
| GOTTO ANTONIO M JR MD D PHIL (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns:
| Disposed/sold 13,916 shares
@ $0 Disposed/sold 10,238 options to buy
@ $9.5, valued at
$97.3k
Disposed/sold 9,988 options to buy
@ $17.64, valued at
$176.2k
Disposed/sold 12,854 options to buy
@ $15, valued at
$192.8k
Disposed/sold 14,700 options to buy
@ $64.73, valued at
$951.5k
Disposed/sold 5,012 options to buy
@ $32.55, valued at
$163.1k
Disposed/sold 18,000 options to buy
@ $17.98, valued at
$323.6k
|
|
11/30/2016 |
4
| Scheer David (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
11/30/2016 |
4
| BARER SOL J (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns:
| Disposed/sold 29,890 shares
@ $0 Disposed/sold 19,927 options to buy
@ $19.25, valued at
$383.6k
Disposed/sold 9,988 options to buy
@ $17.64, valued at
$176.2k
Disposed/sold 12,854 options to buy
@ $15, valued at
$192.8k
Disposed/sold 14,700 options to buy
@ $64.73, valued at
$951.5k
Disposed/sold 5,012 options to buy
@ $32.55, valued at
$163.1k
Disposed/sold 18,000 options to buy
@ $17.98, valued at
$323.6k
|
|
11/04/2016 |
3
| ORLOFF JOHN J (EVP, Research and Development) has filed a Form 3 on Aegerion Pharmaceuticals, Inc. |
09/20/2016 |
4
| Harshbarger Benjamin (General Counsel) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
09/20/2016 |
3
| Menes Remi A (Global Chief Commercial Off.) has filed a Form 3 on Aegerion Pharmaceuticals, Inc. |
09/14/2016 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
09/12/2016 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
09/08/2016 |
3
| Buono Linda (Sr. VP, Human Resources) has filed a Form 3 on Aegerion Pharmaceuticals, Inc. |
07/29/2016 |
4
| SMITH SANDFORD D (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns:
| Paid exercise price by delivering 777 shares
@ $1.55, valued at
$1.2k
Exercised 2,222 restricted stock units
@ $0 |
|
07/05/2016 |
4
| Chan Barbara Y (VP, Chief Accounting Officer) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns:
| Granted 26,000 options to buy
@ $0 |
|
06/24/2016 |
3
| Aegerion Pharmaceuticals, Inc. (10% Owner) has filed a Form 3 on QLT INC/BC |
06/23/2016 |
3
| QLT INC/BC (10% Owner) has filed a Form 3 on Aegerion Pharmaceuticals, Inc. |
06/07/2016 |
3
| Chan Barbara Y (See Remarks) has filed a Form 3 on Aegerion Pharmaceuticals, Inc. |
05/26/2016 |
3/A
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 3/A on Aegerion Pharmaceuticals, Inc. |
05/11/2016 |
4
| Harshbarger Benjamin (Acting General Counsel) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns:
| Granted 5,100 restricted stock units
@ $0 Granted 7,300 restricted stock units
@ $0 |
|
05/11/2016 |
4
| PERRY GREGORY D (See Remarks) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
05/11/2016 |
4
| Louis Roger (Chief Compliance Officer) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
05/11/2016 |
4
| Szela Mary T (CEO) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
05/11/2016 |
4
| Carter Martha J. (See Remarks) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns:
| Granted 26,000 options to buy
@ $0 Granted 13,000 restricted stock units
@ $0 |
|
03/21/2016 |
4
| Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
02/17/2016 |
4
| PERRY GREGORY D (See Remarks) has filed a Form 4 on Aegerion Pharmaceuticals, Inc. |
|
|
|